Unicentric Castleman disease complicated with bronchiolitis obliterans: A single‐centre retrospective study from China
British Journal of Haematology · 2025-04 · 206 (4) · 1129-1135
DOI: 10.1111/bjh.19966 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 29.12.2024. Verfasst von Yan-Ting Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Hauptthemen laut MEDLINE: Castleman Disease, Bronchiolitis Obliterans. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: CAMS Innovation Fund for Medical Sciences, National High Level Hospital Clinical Research Funding, Research and Translation Application of Beijing Clinical Diagnostic Technologies Funds from Beijing Municipal Commission of Science and Technology.
Abstract (Originalsprache)
Bronchiolitis obliterans (BO) is a rare and life‐threatening complication of unicentric Castleman disease (UCD), which is considered the leading cause of death in UCD. However, few studies focused on the characteristics of UCD patients complicated with BO. This single‐centre, retrospective study of 281 patients diagnosed with UCD identified 18 patients (6.4%) with BO. UCD‐BO patients had a significantly lower age at UCD diagnosis than the UCD without BO group. 94.4% of UCD‐BO patients had deep lymph nodes involvement and 83.3% of them had paraneoplastic pemphigus, which were both significantly higher than UCD without BO. Median forced expiratory volume in 1 s of predicted was 20.9% (10%–41.9%) and 83.3% patients had severe BO. All patients underwent complete resection for UCD. 61.1% patients developed BO after surgery. UCD‐BO patients had a poorer overall survival than UCD without BO. Among severe BO, 11 patients did not receive lung transplantation and two of them died, with 62.5% (95% CI, 20.8%–100%) of estimated 5‐year overall survival. Four patients underwent lung transplantation and they all survived. UCD‐BO patients had distinct clinical identity. Complete resection could neither alleviate BO nor prevent BO progression. Lung transplantation is a vital treatment for improving prognosis for patients with severe BO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of International Medical Service, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Yan-Ting Liu, Yu-Han Gao, Si-Yuan Li, Yue Dang, Lu Zhang, Jian Li
Förderung
- CAMS Innovation Fund for Medical Sciences
- National High Level Hospital Clinical Research Funding
- Research and Translation Application of Beijing Clinical Diagnostic Technologies Funds from Beijing Municipal Commission of Science and Technology
- Dongcheng District Outstanding Talent Nurturing Program
Zitieren
APA
Liu, Y. T., Zhen, J. F., Gao, Y. H., Li, S. Y., Dang, Y., Xu, H. Y., Zhang, L., & Li, J. (2025). Unicentric Castleman disease complicated with bronchiolitis obliterans: A single‐centre retrospective study from China. British Journal of Haematology, 206(4), 1129-1135. https://doi.org/10.1111/bjh.19966
Vancouver
Liu YT, Zhen JF, Gao YH, Li SY, Dang Y, Xu HY, et al. Unicentric Castleman disease complicated with bronchiolitis obliterans: A single‐centre retrospective study from China. British Journal of Haematology. 2025;206(4):1129-1135. doi:10.1111/bjh.19966
BibTeX
@article{Liu2025,
author = {Liu, Yan-Ting and Zhen, Jun-Feng and Gao, Yu-Han and Li, Si-Yuan and Dang, Yue and Xu, Hao-Yi and Zhang, Lu and Li, Jian},
title = {Unicentric Castleman disease complicated with bronchiolitis obliterans: A single‐centre retrospective study from China},
journal = {British Journal of Haematology},
year = {2025},
volume = {206},
number = {4},
pages = {1129--1135},
doi = {10.1111/bjh.19966}
}
EUVIMED